RSC Pharmaceutics

What would you like to know about RSC Pharmaceutics?

Introducing our Editor-in-Chief

Scope

RSC Pharmaceutics is a new gold open access journal leading the way in the field of Pharmaceutics. This journal publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy.

Research published in RSC Pharmaceutics promotes step-change science in the field of Pharmaceutics, and, as such, all submissions must show clear innovation, be scientifically sound, and have a significant impact on the field. Research sharing new scientific findings from across the areas of chemistry, materials science, biomedical sciences, pharmaceutics and drug delivery are all welcomed.

Topics include but are not limited to:

• Formulation and design of medicines
• Design and characterization of correct dosage forms
• Physicochemical and biological properties of drugs and their carriers
• Drug delivery devices and their mechanisms of release

See who's on the team

Meet RSC Pharmaceutics's Editor-in-Chief and board members.

Author Guidelines

For general guidance on preparing an article please visit our Prepare your article page, the content of which is relevant to all our journals. Please note that RSC Pharmaceutics does not require authors to submit using a specific template, but there are templates available if you wish to use them.

To learn more about the Royal Society of Chemistry's policies and processes, including licensing, experimental data guidelines, peer review and formatting, please refer to our Resources for authors and Experimental data guidelines pages.

Peer review and editorial process

All articles published in RSC Pharmaceutics are subject to external peer review by experts in the field and all manuscripts submitted are handled by a team of internationally recognised Associate Editors, who are all practicing scientists in the field.

The peer review for all articles submitted to the journal consists of the following stages:

Phase 1: Your manuscript is initially assessed by an associate editor to determine its suitability for peer review.

Phase 2: If the manuscript passes the initial assessment process, the associate editor solicits recommendations from at least two reviewers who are experts in the field. They will provide a report along with their recommendation.

Phase 3: The associate editor handling your manuscript makes a decision based on the reviewer reports received. In the event that no clear decision can be made, another reviewer will be consulted.

RSC Pharmaceutics is committed to a rigorous peer review process and expert editorial oversight for all published content. Please refer to our processes and policies for full details including our appeals procedure.

Transparent peer review

To support increased transparency, we offer authors the option of transparent peer review, where the editor’s decision letter, reviewers’ comments and authors’ response for all versions of the manuscript will be published alongside the article under an Open Access Creative Commons licence (CC-BY). Reviewers are anonymous unless they choose to sign their report.

Find out more about our transparent peer review policy.

Ethical Requirements

RSC Pharmaceutics authors, editors, reviewers and published works are required to uphold the Royal Society of Chemistry’s ethical standards. The Royal Society of Chemistry is a member of the Committee on Publication Ethics (COPE) and our ethical standards follow COPE’s core practices and best practice guidelines. In cases where these guidelines are breached or appear to be so, the Royal Society of Chemistry will consult with COPE guidelines and act accordingly.

When a study involves the use of live animals or human subjects, authors must include in the 'methods/experimental' section of the manuscript a statement that all experiments were performed in compliance with the author’s institute’s policy on animal use and ethics; where possible, details of compliance with national or international laws or guidelines should be included. The statement must name the institutional/local ethics committee which has approved the study; where possible, the approval or case number should be provided. A statement that informed consent was obtained for any experimentation with human subjects is required. Reviewers may be asked to comment specifically on any cases in which concerns arise.

For further guidance on author responsibilities and code of conduct, which apply to RSC Pharmaceutics and to all manuscripts submitted to Royal Society of Chemistry journals, please visit our author hub.

Open Access

As a gold open access journal, RSC Pharmaceutics can maximise the potential and visibility of your publications. Our articles are free to read, access and cite by anyone around the world. We are also covering all article processing charges until mid-2026, so you can publish with us for free.

We offer RSC Pharmaceutics authors a choice of two Creative Commons licences: CC BY or CC BY NC. Publication under these licences means that authors retain the copyright of their article, but users are allowed to read, download, copy, distribute, print, search, or link to the full texts of articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. Read our open access statement for further information.

All published articles are deposited with LOCKSS, CLOCKSS, Portico and the British Library for archiving.

Dive into the benefits of open access publishing:

Find out more about open access publishing routes

Explore Royal Society of Chemistry open access journals

Read our Researchers’ voice report in response to Plan S

Subscription information

RSC Pharmaceutics is fully gold open access – articles can be downloaded free from the website with no barriers to access.

Copyright

Copyright is retained by authors when an open access licence is accepted, as with our standard licence to publish agreement. Full and accurate attribution to the original author is required for any re-use of the work. Find out more about copyright, licences and re-use permission.

Get email alerts about RSC Pharmaceutics

For the latest editorial board news, scope details and announcements, sign up for news and issue alerts by using the form below. For any other queries, please get in touch using the contact us form on this page.